Uterine fibroids affect up to 80% of Black women by age 50—significantly higher than other groups. As you approach menopause, understanding how these common growths will be affected is important for your health planning.
Why Fibroids Are More Common in Black Women
Research points to several factors:
- Genetic variations that increase susceptibility
- Vitamin D deficiency (more common in Black women)
- Higher exposure to certain environmental factors
- Differences in hormone metabolism
Black women also tend to develop fibroids at younger ages, have more and larger fibroids, and experience more severe symptoms.
What Happens to Fibroids at Menopause
Because fibroids are fueled by estrogen and progesterone, they typically shrink after menopause when hormone levels decline. However:
During perimenopause: Fluctuating hormones can cause fibroids to grow unpredictably. Symptoms may temporarily worsen before improving.
After menopause: Most fibroids shrink significantly. Symptoms like heavy bleeding resolve as periods stop.
With hormone therapy: HRT may prevent fibroid shrinkage or cause slight regrowth, though usually not enough to cause problems. This should be discussed with your provider.
Managing Fibroids During the Transition
Medical management: Hormonal medications can help control symptoms until menopause brings natural relief.
Minimally invasive procedures: Options like uterine artery embolization or focused ultrasound can reduce fibroids without major surgery.
Surgical options: For severe cases, myomectomy (removing fibroids) or hysterectomy may be considered.
Watchful waiting: If symptoms are manageable and menopause is approaching, waiting for natural shrinkage may be reasonable.
Hormone Therapy Considerations
Having fibroids doesn't automatically rule out hormone therapy, but it requires careful consideration and monitoring. Low-dose or local estrogen options may be preferable. Discuss your specific situation with a provider experienced in managing fibroids.